Logo image of ANRG.CA

ANAERGIA INC-SUB VOTING SHR (ANRG.CA) Stock Fundamental Analysis

TSX:ANRG - CA03253E2069 - Common Stock

2.45 CAD
+0.09 (+3.81%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

2

Overall ANRG gets a fundamental rating of 2 out of 10. We evaluated ANRG against 23 industry peers in the Commercial Services & Supplies industry. ANRG may be in some trouble as it scores bad on both profitability and health. ANRG is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ANRG has reported negative net income.
In the past year ANRG has reported a negative cash flow from operations.
In the past 5 years ANRG always reported negative net income.
ANRG had negative operating cash flow in 4 of the past 5 years.
ANRG.CA Yearly Net Income VS EBIT VS OCF VS FCFANRG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

ANRG has a worse Return On Assets (-15.41%) than 78.26% of its industry peers.
Industry RankSector Rank
ROA -15.41%
ROE N/A
ROIC N/A
ROA(3y)-30.26%
ROA(5y)-19.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ANRG.CA Yearly ROA, ROE, ROICANRG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

With a Gross Margin value of 25.70%, ANRG perfoms like the industry average, outperforming 43.48% of the companies in the same industry.
ANRG's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ANRG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.61%
GM growth 5Y-1.13%
ANRG.CA Yearly Profit, Operating, Gross MarginsANRG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

ANRG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ANRG has been increased compared to 1 year ago.
ANRG has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ANRG is higher compared to a year ago.
ANRG.CA Yearly Shares OutstandingANRG.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
ANRG.CA Yearly Total Debt VS Total AssetsANRG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -2.25, we must say that ANRG is in the distress zone and has some risk of bankruptcy.
ANRG has a worse Altman-Z score (-2.25) than 82.61% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.25
ROIC/WACCN/A
WACC7.76%
ANRG.CA Yearly LT Debt VS Equity VS FCFANRG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.91 indicates that ANRG may have some problems paying its short term obligations.
ANRG's Current ratio of 0.91 is on the low side compared to the rest of the industry. ANRG is outperformed by 60.87% of its industry peers.
A Quick Ratio of 0.81 indicates that ANRG may have some problems paying its short term obligations.
With a Quick ratio value of 0.81, ANRG is not doing good in the industry: 60.87% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.81
ANRG.CA Yearly Current Assets VS Current LiabilitesANRG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

ANRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 80.54%, which is quite impressive.
ANRG shows a small growth in Revenue. In the last year, the Revenue has grown by 3.05%.
Measured over the past years, ANRG shows a small growth in Revenue. The Revenue has been growing by 4.47% on average per year.
EPS 1Y (TTM)80.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.82%
Revenue 1Y (TTM)3.05%
Revenue growth 3Y-4.2%
Revenue growth 5Y4.47%
Sales Q2Q%36.92%

3.2 Future

The Earnings Per Share is expected to grow by 27.24% on average over the next years. This is a very strong growth
Based on estimates for the next years, ANRG will show a very strong growth in Revenue. The Revenue will grow by 32.78% on average per year.
EPS Next Y52.38%
EPS Next 2Y27.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year42.04%
Revenue Next 2Y32.78%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ANRG.CA Yearly Revenue VS EstimatesANRG.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
ANRG.CA Yearly EPS VS EstimatesANRG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ANRG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ANRG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ANRG.CA Price Earnings VS Forward Price EarningsANRG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ANRG.CA Per share dataANRG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

ANRG's earnings are expected to grow with 27.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.24%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ANRG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ANAERGIA INC-SUB VOTING SHR

TSX:ANRG (8/29/2025, 7:00:00 PM)

2.45

+0.09 (+3.81%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)N/A N/A
Inst Owners3.15%
Inst Owner ChangeN/A
Ins Owners24.21%
Ins Owner ChangeN/A
Market Cap471.40M
Analysts42.22
Price Target3.06 (24.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)46.78%
Min EPS beat(2)21.57%
Max EPS beat(2)71.99%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)4.66%
Min Revenue beat(2)-7.97%
Max Revenue beat(2)17.28%
Revenue beat(4)2
Avg Revenue beat(4)-6.91%
Min Revenue beat(4)-38.13%
Max Revenue beat(4)17.28%
Revenue beat(8)2
Avg Revenue beat(8)-18.78%
Revenue beat(12)3
Avg Revenue beat(12)-17.23%
Revenue beat(16)3
Avg Revenue beat(16)-18.46%
PT rev (1m)130.77%
PT rev (3m)130.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)20%
EPS NY rev (1m)50%
EPS NY rev (3m)50%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)16.37%
Revenue NY rev (3m)16.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.92
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.21
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.62
BVpS-0.34
TBVpS-0.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.41%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.7%
FCFM N/A
ROA(3y)-30.26%
ROA(5y)-19.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.61%
GM growth 5Y-1.13%
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 136.89%
Cap/Sales 6.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.81
Altman-Z -2.25
F-Score4
WACC7.76%
ROIC/WACCN/A
Cap/Depr(3y)1470.76%
Cap/Depr(5y)2019.96%
Cap/Sales(3y)40.34%
Cap/Sales(5y)55.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.82%
EPS Next Y52.38%
EPS Next 2Y27.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.05%
Revenue growth 3Y-4.2%
Revenue growth 5Y4.47%
Sales Q2Q%36.92%
Revenue Next Year42.04%
Revenue Next 2Y32.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year64.29%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y85.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.21%
OCF growth 3YN/A
OCF growth 5YN/A